SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-17-058388
Filing Date
2017-11-13
Accepted
2017-11-13 16:31:49
Documents
1
Group Members
PETER KOLCHINSKY

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv479173_sc13d-a.htm SC 13D/A 41842
  Complete submission text file 0001144204-17-058388.txt   43701
Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Subject) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13D/A | Act: 34 | File No.: 005-88797 | Film No.: 171196378
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1